Intriguingly, inhibition of renin-angiotensin signaling in combination with the anti-VEGF drug Bevacizumab, inactivated tumor endothelial YAP and reduced the fibroblast-induced metastatic TME stiffness and tumor vasculature (142). This evidence concerns the gene REN and neoplasm.